Saves the questions and what to expect into your notes, next to the visit they belong to.
Keep this study
Lead
Duramed Research
Participants will be randomized to either a 91-day OC or a 28-day OC. Participants not seeking hormonal contraception who meet eligibility criteria will serve as a control group. Duration of the study for each study participant will be approximately 13 months.
Age
12–18
Sex
FEMALE
Healthy volunteers
Accepted
You may be eligible if
Healthy postmenarchal adolescent female 12-18 years old, non-pregnant, nonlactating
Regular spontaneous menstrual cycles
Body mass index (BMI): 18 kg/m² to \<30 kg/m², weight \< 200 lbs
Others as dictated by the Food and Drug Administration (FDA)-approved protocol
You may not be if
Any contraindication to the use of oral contraceptives
History of previous clinically significant adverse event while taking hormonal contraceptives
Use of any medication which could significantly interfere with study assessments
Others as dictated by FDA-approved protocol
Clareo Health | A Multicenter Study to Evaluate the Effects of a 91-day Oral Contraceptive on Bone Mineral Density in Adolescent Females
